Clinical TrialID 6737
Alpha-Bisabolol Gel With Antihistamine Action
NCT05022108
Wounds and Injuries
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6737
- Evidence Id
- 6737
- Core Evidence Id
- 6737
- Source Clinical Trial Id
- 6725
- Herb2 Clinical Trial Id
- HBCT006725
- Nct Id
- NCT05022108
- Title
- Alpha-Bisabolol Gel With Antihistamine Action
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Wounds and Injuries
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- BIOLOGICAL: Alpha bisabolol gel
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 20
- Outcome Measure
- Measure of the area (cm2) sensitized with histamine only, Positive control sensitized with a drop of histamine at a concentration of 10 mg / Ml, and after 15 minutes the area sensitized will be measure, 15 minutes|Measure of the area (cm2) sensitized by histamine treated with 0,5% Alpha bisabolol, Histamine will be applied and immediately after, the alpha bisabolol gel with a concentration of 0.5%, and after 15 minutes the area sensitized will be measure, 15 minutes|Measure of the area sensitized by histamine treated with 2,5% Alpha bisabolol, Histamine will be applied and immediately after, the alpha bisabolol gel with a concentration of 2,5% will applied, and after 15 minutes the area sensitized will be measure, 15 minutes|Measure of the area (cm2) sensitized by histamine treated with 5% Alpha bisabolol, It will be sensitized with a drop of histamine and immediately with 5.0% alpha-bisabolol gel, and after 15 minutes the area sensitized will be measure, 15 minutes
- Sponsor Collaborator
- Universidade do Vale do Sapucai
- Funded By
- OTHER
- Location
- Vale do Sapucaí University, Pouso Alegre, Minas Gerais, 37550-000, Brazil
- Other Id
- Antihistamine
- Start Date
- 2020-04-01
- Primary Completion Date
- 2020-08-01
- Completion Date
- 2020-12-20
- First Posted
- 2021-08-26
- Results First Posted
- Last Update Posted
- 2021-08-31
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05022108
- Title Cn
- Title En
- Alpha-Bisabolol Gel With Antihistamine Action
- Bilingual Status
- semi_complete